Chase AIBulk Dataset ExportPricingFAQsBlog
Display currency
Loading news…

DeCODE Genetics

Reykjavík, Gullbringusysla, Iceland

DeCODE Genetics is a biopharmaceutical company that develops and offers diagnostic tests for variants in genes.

DeCODE Genetics on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.

DeCODE Genetics was acquired by Amgen in 2012 for $415M.
Funding Rounds
1
Last Funding
Acquisitions
1
Monthly Visits
Contacts
41

About DeCODE Genetics

Funding & Financials

Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

Web Traffic

Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Company Info

Org types
company
HQ
Reykjavík, Gullbringusysla, Iceland

DeCODE Genetics Funding Rounds

1 results
Upgrade to Pro to view this datasetUpgrade
Organization NameFunding TypeLead Investor NamesOrg Hq Country
1–1 of 1Show
Page 1 / 1

DeCODE Genetics Acquisitions

1 results
Acquiree NameAcquirer NameAcquiree IndustriesAcquiree Hq Country
MediChem Life Sciences$83.6M2002-01-14DeCODE GeneticsBiotechnologyMedicalUnited States
1–1 of 1Show
Page 1 / 1

DeCODE Genetics Key People

Founder and CEO
Vice President of Research
Vice President of Statistics
Vice President of Informatics
41
professional contacts at DeCODE Genetics
Contact execs at DeCODE Genetics

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions
Bulk Dataset Export

Need the data in bulk? Buy the entire dataset.

5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools

Delivered as CSV, JSON or Parquet — at startup-friendly pricing.

See bulk export

FAQs about DeCODE Genetics

People who checked this page also checked these

Sectors DeCODE Genetics invests & acquires in

M&A by year

Browse the full Acquirezy directory.